Double Stuff News Today

Can GLP-1 drugs for obesity and diabetes, like Ozempic and Wegovy, help change the food industry? Consumers on these drugs experience a decline in their appetite and their appeal for sugary snacks filled with fats and sodium. Could this inspire consumer products companies to create healthier snacks?

Can GLP-1 drugs for obesity and diabetes, like Ozempic and Wegovy, help change the food industry? Consumers on these drugs experience a decline in their appetite and their appeal for sugary snacks filled with fats and sodium. Could this inspire consumer products companies to create healthier snacks?

The sun is shining and it’s not raining, but the wind is howling outside as I sit in my writing eyrie trying to come up with a column for this week. 

I don't know anyone who doesn't love Oreos.

Oreo fans believe they’ve uncovered the latest and biggest scandal yet in “shrinkflation” across consumer goods — claiming that the crucial creme-to-cookie ratio has been quietly shrinking in their favorite snack.

Oreos are the latest victim of the "shrinkflation" phenomenon that has businesses everywhere quietly shrinking their offerings without lowering prices

Double the fun

Since this limited edition cookie was last seen on shelves in 2020, Oreo fans have been begging for the flavor to make its triumphant return. And now it’s here.

In a viral TikTok, a man questions the reason for an 'Extra Stuf' variety of Oreo Thins, sparking debate on the platform.

Experts from Stanford looked at of coronary artery disease rates and cannabis use among 175,000 people across the US. Daily users were 34% more likely to develop the disease than non-users.